Efficacy of Mogamulizumab in patients with acute and lymphoma type adult T cell leukemia/lymphoma: a single center, retrospective study

Trial Profile

Efficacy of Mogamulizumab in patients with acute and lymphoma type adult T cell leukemia/lymphoma: a single center, retrospective study

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Dec 2017

At a glance

  • Drugs Mogamulizumab (Primary)
  • Indications Adult T-cell leukaemia-lymphoma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 26 Dec 2017 New trial record
    • 12 Dec 2017 Results assessing efficacy, presented at the 59th Annual Meeting and Exposition of the American Society of Hematology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top